Maria Vilenchik

1.2k total citations
20 papers, 931 citations indexed

About

Maria Vilenchik is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Maria Vilenchik has authored 20 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Maria Vilenchik's work include DNA and Nucleic Acid Chemistry (5 papers), RNA Interference and Gene Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Maria Vilenchik is often cited by papers focused on DNA and Nucleic Acid Chemistry (5 papers), RNA Interference and Gene Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Maria Vilenchik collaborates with scholars based in United States, Switzerland and Russia. Maria Vilenchik's co-authors include Gabriela Chiosis, David B. Solit, Joungnam Kim, Aharon S. Cohen, Neal Rosen, Christian Stein, John F. Boylan, Huazhong He, Paul Modrich and Claudia P. Spampinato and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Maria Vilenchik

18 papers receiving 897 citations

Peers

Maria Vilenchik
Suman Chatterjee United States
Marton I. Siklos United States
Hao Shao United States
Oliver Demmer Germany
Weiwen Ying United States
Haim Barr Israel
H. Christian Eberl Germany
Shradha Singh Canada
Kevin Leung United States
Marissa Powers United Kingdom
Suman Chatterjee United States
Maria Vilenchik
Citations per year, relative to Maria Vilenchik Maria Vilenchik (= 1×) peers Suman Chatterjee

Countries citing papers authored by Maria Vilenchik

Since Specialization
Citations

This map shows the geographic impact of Maria Vilenchik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Vilenchik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Vilenchik more than expected).

Fields of papers citing papers by Maria Vilenchik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Vilenchik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Vilenchik. The network helps show where Maria Vilenchik may publish in the future.

Co-authorship network of co-authors of Maria Vilenchik

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Vilenchik. A scholar is included among the top collaborators of Maria Vilenchik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Vilenchik. Maria Vilenchik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vilenchik, Maria, et al.. (2022). Novel Efficient Multistage Lead Optimization Pipeline Experimentally Validated for DYRK1B Selective Inhibitors. Journal of Medicinal Chemistry. 65(20). 13784–13792. 6 indexed citations
3.
Vilenchik, L.Z. & Maria Vilenchik. (2019). The Emergence and Evolution of the Universe. Journal of High Energy Physics Gravitation and Cosmology. 5(3). 884–898.
4.
Rutkowska, Ewelina, et al.. (2019). How to design potent and selective DYRK1B inhibitors? Molecular modeling study. Journal of Molecular Modeling. 25(2). 41–41. 9 indexed citations
5.
Kuznetsova, Alexandra, et al.. (2019). Abstract 3038: Implication of DYRK1B Kinase in ovarian cancers and utilization of DYRK1B Inhibitors as a novel therapeutic strategy for ovarian cancer. Cancer Research. 79(13_Supplement). 3038–3038. 1 indexed citations
6.
Vilenchik, Maria, Alexandra Kuznetsova, Arianna Damiani, et al.. (2019). Implication of DYRK1B kinase in dormant glioblastoma cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for glioblastoma.. Journal of Clinical Oncology. 37(15_suppl). e14670–e14670. 1 indexed citations
7.
Vilenchik, Maria, et al.. (2017). Abstract 3195: DYRK1B inhibitors prevent pharmacologic quiescence and sensitize lung cancers to EGFR inhibitors. Cancer Research. 77(13_Supplement). 3195–3195. 1 indexed citations
8.
Ewton, Daina Z., Jing Hu, Maria Vilenchik, et al.. (2011). Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 10(11). 2104–2114. 56 indexed citations
9.
Luistro, Leopoldo, Wei He, Melissa Smith, et al.. (2009). Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties. Cancer Research. 69(19). 7672–7680. 154 indexed citations
10.
Rodina, Anna, Maria Vilenchik, Kamalika Moulick, et al.. (2007). Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nature Chemical Biology. 3(8). 498–507. 129 indexed citations
11.
Chiosis, Gabriela, Maria Vilenchik, Joungnam Kim, & David B. Solit. (2004). Hsp90: the vulnerable chaperone. Drug Discovery Today. 9(20). 881–888. 173 indexed citations
12.
Vilenchik, Maria, David B. Solit, Andrea Basso, et al.. (2004). Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90. Chemistry & Biology. 11(6). 787–797. 131 indexed citations
13.
Vilenchik, Maria, et al.. (2003). Microtiter Cell-Based Assay for Detection of Agents that Alter Cellular Levels of Her2 and EGFR. Chemistry & Biology. 10(7). 629–634. 19 indexed citations
14.
Vilenchik, Maria, Anthony J. Raffo, Luba Benimetskaya, David S. Shames, & Christian Stein. (2002). Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.. PubMed. 62(7). 2175–83. 37 indexed citations
15.
16.
Benimetskaya, Lyuba, et al.. (1998). Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Research. 26(23). 5310–5317. 62 indexed citations
17.
Vilenchik, Maria, Alexei Belenky, & Aharon S. Cohen. (1994). Monitoring and analysis of antisense DNA by high-performance capillary gel electrophoresis. Journal of Chromatography A. 663(1). 105–113. 18 indexed citations
18.
Berka, Jan, David N. Heiger, Thomas Schmitt, et al.. (1993). Separation of DNA fragments by capillary electrophoresis using replaceable linear polyacrylamide matrices. Journal of Chromatography A. 652(1). 57–66. 83 indexed citations
19.
Cohen, Aharon S., et al.. (1993). High-performance liquid chromatography and capillary gel electrophoresis as applied to antisense DNA. Journal of Chromatography A. 638(2). 293–301. 46 indexed citations
20.
Vilenchik, Maria, et al.. (1988). Effect of ?-carotene on toxic genetic injuries in the liver during formation and action of the carcinogen N-nitrosodimethylamine. Bulletin of Experimental Biology and Medicine. 106(4). 1483–1485.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suman Chatterjee Breakdown of academic impact, for papers by Marton I. Siklos Breakdown of academic impact, for papers by Hao Shao Breakdown of academic impact, for papers by Oliver Demmer Breakdown of academic impact, for papers by Weiwen Ying Breakdown of academic impact, for papers by Haim Barr Breakdown of academic impact, for papers by H. Christian Eberl Breakdown of academic impact, for papers by Shradha Singh Breakdown of academic impact, for papers by Kevin Leung Breakdown of academic impact, for papers by Marissa Powers
Rankless by CCL
2026